Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 20th September 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BHA issues warning over products containing altrenogest
BHA is carrying out further work to understand the implications of this issue in Europe. 

Trace levels of anabolic steroids found in some products 

The British Horseracing Authority (BHA) is making vets and trainers aware of an international issue regarding products that contain altrenogest.

Trace levels of the anabolic steroids trenbolone and/or trendione have been detected in products containing altrenogest, which is commonly referred to by its trade name, Regumate.

Racing Victoria (Australia) has advised trainers to immediately cease using such products and further investigations are now underway.

In the UK, one such product is licensed for use in horses - Regumate Equine 2.2mg/ml Oral Solution for Horses (MSD Animal Health).

After discussions with the European manufacturer, BHA said it can confirm that the product distributed in the UK is reportedly sourced from a separate location to the products that are currently under investigation.

However, in light of the international situation, BHA is strongly advising trainers to be cautious if using altrenogest in racing thoroughbreds.

The BHA published Detection Time for altrenogest is 288 hours (15 days). In contrast, a 24-hour withdrawal from racing is recommended in Australia for mares and fillies receiving oral altrenogest.

BHA is carrying out further work to understand the implications of this issue in Europe.  

 

Become a member or log in to add this story to your CPD history

BEVA gives RVNs right to vote

News Story 1
 The British Equine Veterinary Association (BEVA) is to allow its registered veterinary nurse (RVN) members the right to vote.

RVN members will now be able to take part in key decision-making processes and stand for BEVA council.

Marie Rippingale, chair of BEVA's Nurse Committee, said: "I am very proud to be a part of BEVA.

"This change will help to empower nurses to speak up and contribute, but more importantly, it will give them an opportunity to collaborate with other members of the equine veterinary profession to bring about change that is positive for all." 

Click here for more...
News Shorts
Northern Ireland chief vet warns of bluetongue risk

Following the detection of bluetongue virus serotype 3 (BTV-3) in England, Northern Ireland's chief veterinary officer has urged farmers to remain vigilant and source animals responsibly.

Brian Dooher said: "This confirmation in England is a stark reminder of the threat bluetongue presents to Northern Ireland.Whilst this finding in Norfolk is disappointing it is not unexpected giving the rising level of disease across several countries in Europe. Bluetongue does not affect human health or food safety, however an incursion to Northern Ireland would have a significant impact on livestock and the rural economy.

"I would like to remind all farmers of the importance of sourcing animals responsibly and ask that they maintain vigilance for signs of the disease reporting any suspicions to DAERA immediately."

Suspected cases of BTV-3 in Northern Ireland should be reported to the DAERA Helpline on 0300 200 7840 or by contacting the local DAERA Direct Veterinary Office.